IXICO plc (AIM:IXI)
London
· Delayed Price · Currency is GBP · Price in GBX 10.15
-0.10 (-0.98%)
Jun 27, 2025, 4:35 PM GMT+1
IXICO Revenue
IXICO had revenue of 3.21M GBP in the half year ending March 31, 2025, with 0.16% growth. This brings the company's revenue in the last twelve months to 6.44M, up 7.27% year-over-year. In the fiscal year ending September 30, 2024, IXICO had annual revenue of 5.77M, down -13.49%.
Revenue (ttm)
6.44M
Revenue Growth
+7.27%
P/S Ratio
1.46
Revenue / Employee
79.46K
Employees
81
Market Cap
9.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 5.77M | -899.00K | -13.49% |
| Sep 30, 2023 | 6.67M | -1.98M | -22.89% |
| Sep 30, 2022 | 8.64M | -547.00K | -5.95% |
| Sep 30, 2021 | 9.19M | -342.00K | -3.59% |
| Sep 30, 2020 | 9.53M | 1.97M | 26.07% |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
IXICO News
- 7 months ago - IXICO PLC (FRA:PYPB) (Q4 2024) Earnings Call Highlights: Strong Revenue Growth and Strategic ... - GuruFocus
- 7 months ago - Full Year 2024 IXICO PLC Earnings Call Transcript - GuruFocus
- 7 months ago - Small Cap Stocks: Eco Buildings, IXICO, Electric Guitar - The Armchair Trader